MacroChem undertakes no obligation to publicly update any forward-looking statements.

MacroChem undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. For further information visit our website.

DeLuccia also found.: We believe that in a valid, well tolerated and easy to use current onychomycosis therapy could both attract patients currently receiving other treatments and also expand the existing market for patients who are not. . Continue reading “MacroChem undertakes no obligation to publicly update any forward-looking statements.”